In a significant shift within the German healthcare landscape, the number of children and adolescents receiving a new diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) has surged. According to a comprehensive analysis by the DAK-Gesundheit, one of Germany’s major health insurance providers, the country recorded a 16 percent increase in new ADHD diagnoses in 2024 compared to the previous year. This statistical spike—representing roughly 202,000 newly diagnosed young people—is fueling urgent debates among medical professionals, policymakers, and families regarding the root causes, the potential for overdiagnosis, and the necessity of improved mental health infrastructure.
The Core Data: A Demographic Breakdown
The data provided by the DAK-Gesundheit offers a granular look at the prevalence of the condition across different age and gender cohorts. Historically, ADHD has been identified more frequently in boys, a trend that persists in the 2024 data. Of the 202,000 new diagnoses, approximately 136,500 were boys, while 65,000 were girls.
However, the rate of growth is notably disparate between the genders. While the number of new diagnoses among boys rose by roughly 14 percent, the increase among girls was significantly more pronounced at 21 percent. This suggests a narrowing of the diagnostic gap that has traditionally left many girls with the condition overlooked.
The surge is not confined to a single age group. Every bracket saw an increase, with school-aged children between 10 and 14 years experiencing the most dramatic growth—a 22 percent jump. By the end of 2024, approximately 18 out of every 1,000 schoolchildren received an initial ADHD diagnosis, up from 15 per 1,000 in the previous year. The highest incidence, however, remains among primary school children; specifically, among five- to nine-year-olds, nearly 24 per 1,000 children were diagnosed with the disorder for the first time in 2024.
Chronology of a Shifting Landscape
To understand the current surge, one must look at the recent historical context of mental health trends in Germany. As of 2024, the total number of children and adolescents aged 3 to 17 living with an ADHD diagnosis in Germany reached approximately 617,000.
To put this into perspective, the number stood at 556,500 in 2019, before the onset of the global pandemic. During the height of the COVID-19 crisis, the numbers took an unexpected dip, falling to a low of 540,500 in 2022. At the time, the DAK suggested that this decline was likely not a reflection of lower disease prevalence, but rather a consequence of restricted access to medical care and therapy during lockdowns.
The "normalization" of the healthcare system following the pandemic appears to have released a pent-up demand for mental health assessments. The sharp increase observed in 2023 and 2024 may, in part, be a reflection of these "catch-up" effects, where families finally sought the professional evaluations that were postponed during the preceding years. Whether this explains the entirety of the 16 percent increase remains an open question for researchers.
Defining the Challenge: What is ADHD?
ADHD remains the most frequently diagnosed mental health disorder among children and adolescents in Germany, with the potential to persist into adulthood. The disorder is characterized by a complex interplay of genetic factors and environmental influences.
Common symptoms include an intense physical restlessness, difficulty in maintaining focus on tasks that do not provide immediate stimulation, and a tendency toward impulsive, unconsidered behavior. However, medical experts are quick to clarify that ADHD is a spectrum. As noted by the editorial staff at the DAK report, it is vital to emphasize that not every child with an ADHD diagnosis presents the same symptoms in the same way. The expression of the disorder is highly individual, varying in severity and type.
Expert Perspectives: Avoiding the "Fashion Diagnosis" Label
In the public discourse, the increase in diagnoses often prompts accusations of "overdiagnosis" or the labeling of common childhood behaviors as medical conditions. Experts are firmly pushing back against these narratives.
"ADHD is not a ‘fashion diagnosis,’" asserts Professor Christoph Correll, Director of the Clinic for Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy at the Berlin Charité. Professor Correll points to a more nuanced reality: that our modern environment is placing unprecedented pressure on children. Increased stress, the rapid pace of digital life, and the often-detrimental influence of social media can act as catalysts. In children with a genetic predisposition, these external factors may cause a latent psychological issue to manifest more clearly, making it easier for doctors to identify the need for support.
Furthermore, there is a growing societal awareness. As mental health becomes a more prominent topic in public discourse, parents and teachers are more likely to recognize the signs of ADHD, leading to more frequent consultations with pediatricians.
Implications for Public Policy and Healthcare
The surge in diagnoses has brought the issue of care capacity to the forefront of German healthcare policy. DAK CEO Andreas Storm has called for a more robust and integrated approach to the care of young people. "Only through better networking in the supply chain can these children be stabilized and supported early on, before their burdens become permanent," Storm stated.
The significant rise in diagnoses among girls has also caught the attention of the medical community. Michael Hubmann, President of the Professional Association of Pediatricians and Youth Doctors (BVKJ), views this increase as a corrective measure. For years, the prevailing medical view was skewed toward the hyperactive, disruptive profile often seen in boys. Consequently, girls—who may present with more internalizing symptoms such as inattentiveness or emotional dysregulation rather than outward physical restlessness—were frequently overlooked. The current data, according to Hubmann, suggests that the medical system is finally beginning to identify these previously under-diagnosed cases.
The Path Forward: Integration and Early Support
The path forward for German mental health services involves a transition from reactive care to proactive support. With 617,000 children and adolescents now formally diagnosed, the pressure on the therapeutic system is immense. Wait times for child psychologists and psychiatrists in many parts of Germany are already significant, and the recent spike in new cases threatens to exacerbate these bottlenecks.
Experts suggest several key areas for development:
- Enhanced Training for Educators: Teachers are often the first to notice the signs of ADHD. Providing them with the tools to distinguish between typical developmental stages and actual neurological challenges is essential for timely referrals.
- Integrated Care Models: As DAK-CEO Andreas Storm suggests, bridging the gap between schools, pediatricians, and specialized therapists is critical to ensure that a diagnosis is not an end point, but the beginning of a support structure.
- Gender-Sensitive Diagnostic Criteria: Continued refinement of how ADHD is assessed, specifically regarding the different ways it manifests in girls versus boys, is necessary to ensure equitable access to care.
Conclusion
The 16 percent increase in ADHD diagnoses in Germany is a multifaceted phenomenon. While it reflects a return to medical care following the disruptions of the pandemic, it also highlights an evolving understanding of mental health and a more accurate identification of symptoms in previously overlooked populations.
Rather than viewing these numbers as an alarmist trend of "over-pathologizing" childhood, many experts suggest they represent a necessary shift toward acknowledging the challenges faced by today’s youth. As societal pressures, digital connectivity, and academic expectations continue to evolve, the medical community’s ability to respond with early, personalized, and accessible support will be the defining factor in the well-being of the next generation. The challenge now lies not in curbing the diagnoses, but in ensuring that the system is equipped to provide the care that these 617,000 young people—and the many who will follow—rightfully require.
